dihexa pnb-0408 c-met hgfr activator Pancreatic Cancer Treatment Targeting the HGF/c-MET Pathway: The MEK Inhibitor Trametinib HGF/Met Signaling in Head and
HGF Met Signaling in Head and Neck Cancer: Impact on the Tumor Microenvironment PMC dihexa peptide cognitive enhancement neurodegeneration Growth Factors and Their Application in the Therapy of Hereditary Neurodegenerative Diseases Dihexa (PNB 0408) c Met HGFR Activator dihexa peptide oral Neural Growth Factor Support in Central Florida: for Focus, Memory, and Stress Relief Dihexa (PNB 0408) c Met HGFR Activator Dimethyl fumarate Nrf2 Activator MedChemExpress Targeting HGF c MET signaling to regulate the tumor microenvironment: Implications for counteracting tumor immune evasion PMC Targeting the oncogenic Met receptor by antibodies and gene therapy Oncogene
Pay in 4 interest-free payments of $5.63 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8





